Cardiopulmonary interaction in heart failure

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 2, 2007, Pages 130-134

  Agostoni, Piergiuseppe ^a,b   Cattadori, Gaia ^a   Bussotti, Maurizio ^a   Apostolo, Anna ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiomegaly; Exercise; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BODY FLUID; BREATHING RATE; CARDIOPULMONARY FUNCTION; DISEASE SEVERITY; EVALUATION; EXERCISE; HEART FAILURE; HUMAN; HYPERVENTILATION; LUNG DEAD SPACE; LUNG DIFFUSION; LUNG FLUID; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION;

ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANOXIA; EXERCISE; HEART FAILURE, CONGESTIVE; HUMANS; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY;

EID: 33751197306     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.03.001     Document Type: Review

References (29)

1. Wasserman K., Zhang Y., Gitt A., Belardinelli R., Koike A., Lubarsky L., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 96 (1997) 2221-2227
2. Agostoni P.G., Marenzi G.C., Sganzerla P., Assanelli E., Guazzi M., Perego G.B., et al. Lung-heart interaction as a substrate for the improvement in exercise capacity following body fluid volume depletion in moderate congestive heart failure. Am J Cardiol 76 (1995) 793-798
3. Agostoni P., Cattadori G., Guazzi M., Melzi G., Lomanto M., De Vita S., et al. Cardiomegaly as a possible cause of lung dysfunction in heart failure patients. Am Heart J 140 (2000) e24
4. Palermo P., Cattadori G., Bussotti M., Apostolo A., Contini M., and Agostoni P. Lateral decubitus position generates discomfort and worsens lung function in chronic heart failure. Chest 128 (2005) 1511-1516
5. Agostoni P., Bussotti M., Palermo P., and Guazzi M. Does lung diffusion impairment affect exercise capacity in patients with heart failure?. Heart 88 (2002) 453-459
6. Sue D.Y., Oren A., Hansen J.E., et al. Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise. N Engl J Med 316 (1987) 1301-1306
7. Puri S., Baker B.L., Dutka D.P., et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Circulation 91 (1995) 2769-2774
8. Smith A.A., Cowburn P.J., Parker M.E., et al. Impaired pulmonary diffusion during exercise in patients with chronic heart failure. Circulation 100 (1999) 1406-1410
9. Guazzi M., Marenzi G.C., Alimento M., et al. Improvement of alveolar capillary diffusing capacity in chronic heart failure and counteracting effects of aspirin. Circulation 95 (1997) 1930-1936
10. Guazzi M., Marenzi G.C., Melzi G., et al. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation perfusion coupling in patients with left ventricular dysfunction. Clin Pharmacol Ther 65 (1999) 319-327
11. Koike A., Wasserman K., McKenzie D.K., et al. Evidence that diffusion limitation determines oxygen uptake kinetics during exercise in humans. J Clin Invest 86 (1990) 11698-11706
12. Abinader E.G., Sharif D.S., and Goldhammer E. Effects of low altitude on exercise performance in patients with congestive heart failure after healing of acute myocardial infarction. Am J Cardiol 83 (1999) 383-387
13. Moore P., Weston A., Hughes J.M.B., et al. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 339 (1992) 850-853
14. O'Donnel D.E., D'Arsigny C., Ray S., et al. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med 160 (1999) 1804-1811
15. Sullivan M.J., Higginbotham M.B., and Cobb F.R. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory controll despite hemodynamic and pulmonary abnormalities. Circulation 77 (1988) 552-559
16. Kleber F.X., Vietzke G., Wernecke K.D., Bauer U., Opitz C., Wensel R., et al., Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 101 (2000) 2803-2809
17. Ponikowski P., Chua T.P., Piepoli M., Ondusova D., Webb-Peploe K., Harrington D., et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96 (1997) 2586-2594
18. Myers J., Salleh A., Buchanan N., Smith D., Neutel J., Bowes E., et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 124 (1992) 710-719
19. Agostoni P.G., Marenzi G.C., Pepi M., Doria E., Salvioni A., Perego G.B., et al. Isolated ultrafiltration for moderate heart failure. J Am Coll Cardiol 21 (1993) 424-431
20. Agostoni P., Pellegrino R., Conca C., Rodarte J., and Brusisco V. Exercise hyperpnea in chronic heart failure: relation to lung stiffness and exercise flow limitation. J Appl Physiol 92 (2002) 1409-1416
21. Chua T.P., Clark A.L., Amadi A.A., and Coats A.J. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 27 (1996) 650-657
22. Chua T.P., Harrington D., Ponikowski P., Webb-Peploe K., Poole-Wilson P.A., and Coats A.J. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29 (1997) 147-152
23. Ponikowski P., Francis D.P., Piepoli M.F., Davies L.C., Chua T.P., Davos C.H., et al., Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 103 (2001) 967-972
24. Scott A.C., Francis D.P., Coats A.J.S., and Piepoli M.F. Reproducibility of the measurement of the muscle ergoreflex ativity in chronic heart failure. Eur Heart Fail 5 (2003) 453-461
25. Robbins M., Francis G., Pashkow F.J., Snader C.E., Hoercher K., Young J.B., et al. Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak oxygen consumption. Circulation 100 (1999) 2411-2477
26. Johnson B.D., Weisman I.M., Zeballos R.J., and Beck K.C. Emerging concepts in the evaluation of ventilatory limitation during exercise. The exercise tidal flow-volume loop. Chest 116 (1999) 488-503
27. Agostoni P., Guazzi M., Bussotti M., De Vita S., and Palermo P. Carvedilol reduces the inappropriate increase of ventilation during exerise in heart failure patients. Chest 122 (2002) 2062-2067
28. Agostoni P., Magini A., Andreini D., Contini M., Apostolo A., Bussotti M., et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J 26 (2005) 159-164
29. Agostoni P.G., Guazzi M., Bussotti M., Grazi M., Palermo P., and Marenzi G. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 36 (2000) 1600-1604